Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Alasdair Coles, Rupert Sandbrink, Howard L. Weiner, Krzysztof Selmaj, Douglas L. Arnold, D. A. S. Compston, Christian Confavreux, Eva Havrdová, Michael Panzara, Cary Twyman, Jeffrey Cohen, Edward Fox, Hans-Peter Hartung, Tamara Miller, Elizabeth Fisher, Stephen Lake, David Margolin, Pedro Oyuela
2012-11-01
SCID:  54.1/zesk2kfd
Publication Details
Publication Date
2012-11-01
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Alasdair Coles
Rupert Sandbrink
Howard L. Weiner
Krzysztof Selmaj
Douglas L. Arnold
D. A. S. Compston
Christian Confavreux
Eva Havrdová
Michael Panzara
Cary Twyman
Jeffrey Cohen
Edward Fox
Hans-Peter Hartung
Tamara Miller
Elizabeth Fisher
Stephen Lake
David Margolin
Pedro Oyuela
Explore More Research
Use the citation graph to discover related papers and expand your research horizons.
Click any node to explore →
Download PDF
100%